Skip to main content
. Author manuscript; available in PMC: 2018 Jun 6.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2008 May 30;49(11):5077–5082. doi: 10.1167/iovs.08-1837

Table 3.

KIR Genotype and Haplotype Frequencies in Southampton AMD and Control Groups

KIR
Genotypes
AMD Group
n = 104 (%)
Control Group
n = 93 (%)
P* OR 95% CI
    2DL1   101 (97.1) 91 (97.8) 0.74 0.74 0.12–4.52
    2DL2  50 (48.1) 48 (51.6) 0.24 0.87 0.50–1.52
    2DL3  98 (94.2) 90 (96.8) 0.39 0.54 0.13–2.24
    2DL4   103 (99.0)   93 (100.0) 0.34 1.90 1.67–2.17
    2DL5  38 (36.5) 52 (55.9) 0.006 0.45 0.26–0.80
    2DS1  36 (34.6) 43 (46.2) 0.09 0.61 0.35–1.09
    2DS2  50 (48.1) 50 (53.8) 0.42 0.79 0.45–1.39
    2DS3  25 (24.0) 32 (34.4) 0.10 0.60 0.32–1.12
    2DS4  95 (91.3) 89 (95.7) 0.21 0.47 0.14–1.59
    2DS5  27 (26.0) 28 (30.1) 0.51 0.81 0.44–1.52
    3DL1   101 (97.1) 90 (96.8) 0.89 1.12 0.22–5.70
    3DL2   104 (100.0)   93 (100.0)    —
    3DL3   104 (100.0) 92 (98.9) 0.29 3.38 0.13–84.3
    3DS1  30 (28.8) 34 (36.6) 0.24 0.70 0.38–1.28
    2DP1   101 (97.1) 91 (97.8) 0.74 0.74 0.12–4.53
    3DP1   104 (100.0)   93 (100.0)    —
    AA  35 (33.7) 23 (24.7) 0.17 1.54 0.82–2.87
    AB/BB  69 (66.3) 70 (75.3) 0.17 0.65 0.34–1.20
*

Two-sided probabilities; χ2 test.

OR according to the approximation of Woolf.

Significant values.